129 related articles for article (PubMed ID: 38752748)
61. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains.
van der Aa Kühle A; Skovgaard K; Jespersen L
Int J Food Microbiol; 2005 May; 101(1):29-39. PubMed ID: 15878404
[TBL] [Abstract][Full Text] [Related]
62. Effect of microencapsulation on
Ghorbani-Choboghlo H; Nikaein D; Khosravi AR; Rahmani R; Farahnejad Z
Iran J Microbiol; 2019 Apr; 11(2):160-165. PubMed ID: 31341571
[TBL] [Abstract][Full Text] [Related]
63. Effect of probiotic Saccharomyces boulardii in experimental giardiasis.
Ribeiro MRS; Oliveira DR; Oliveira FMS; Caliari MV; Martins FS; Nicoli JR; Torres MF; Andrade MER; Cardoso VN; Gomes MA
Benef Microbes; 2018 Sep; 9(5):789-797. PubMed ID: 30165752
[TBL] [Abstract][Full Text] [Related]
64. Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System.
Hudson LE; McDermott CD; Stewart TP; Hudson WH; Rios D; Fasken MB; Corbett AH; Lamb TJ
PLoS One; 2016; 11(4):e0153351. PubMed ID: 27064405
[TBL] [Abstract][Full Text] [Related]
65. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic.
Wombwell E; Bransteitter B; Gillen LR
Mycoses; 2021 Dec; 64(12):1521-1526. PubMed ID: 34585799
[TBL] [Abstract][Full Text] [Related]
66. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties.
Martins FS; Silva AA; Vieira AT; Barbosa FH; Arantes RM; Teixeira MM; Nicoli JR
Arch Microbiol; 2009 Aug; 191(8):623-30. PubMed ID: 19526225
[TBL] [Abstract][Full Text] [Related]
67. Probiotic and Potentially Probiotic Yeasts-Characteristics and Food Application.
Staniszewski A; Kordowska-Wiater M
Foods; 2021 Jun; 10(6):. PubMed ID: 34200217
[TBL] [Abstract][Full Text] [Related]
68.
Albuquerque RCMF; Brandão ABP; De Abreu ICME; Ferreira FG; Santos LB; Moreira LN; Taddei CR; Aimbire F; Cunha TS
Benef Microbes; 2019 Dec; 10(8):901-912. PubMed ID: 31965836
[TBL] [Abstract][Full Text] [Related]
69. Isolation and Characteristics of Extracellular Vesicles Produced by Probiotics: Yeast Saccharomyces boulardii CNCM I-745 and Bacterium Streptococcus salivarius K12.
Kulig K; Kowalik K; Surowiec M; Karnas E; Barczyk-Woznicka O; Zuba-Surma E; Pyza E; Kozik A; Rapala-Kozik M; Karkowska-Kuleta J
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):936-948. PubMed ID: 37209320
[TBL] [Abstract][Full Text] [Related]
70. Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.
Schroeder B; Winckler C; Failing K; Breves G
Dig Dis Sci; 2004 Aug; 49(7-8):1311-7. PubMed ID: 15387362
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of synbiotic combinations of commercial probiotic strains with different prebiotics in in vitro and ex vivo human gut microcosm model.
Raval SD; Archana G
Arch Microbiol; 2024 Jun; 206(7):315. PubMed ID: 38904672
[TBL] [Abstract][Full Text] [Related]
72. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.
Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S
Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908
[TBL] [Abstract][Full Text] [Related]
73. In vitro digestion and characterization of selenized Saccharomyces cerevisiae, Pichia fermentans and probiotic Saccharomyces boulardii.
Hyrslova I; Kana A; Nesporova V; Mrvikova I; Doulgeraki AI; Lampova B; Doskocil I; Musilova S; Kieliszek M; Krausova G
J Trace Elem Med Biol; 2024 May; 83():127402. PubMed ID: 38310829
[TBL] [Abstract][Full Text] [Related]
74. Effects of fructooligosaccharides and Saccharomyces boulardii on the compositional structure and metabolism of gut microbiota in students.
Fu H; Chen Z; Teng W; Du Z; Zhang Y; Ye X; Yu Z; Zhang Y; Pi X
Microbiol Res; 2024 Aug; 285():127741. PubMed ID: 38761487
[TBL] [Abstract][Full Text] [Related]
75. Probiotic potential of yeasts isolated from pineapple and their use in the elaboration of potentially functional fermented beverages.
Amorim JC; Piccoli RH; Duarte WF
Food Res Int; 2018 May; 107():518-527. PubMed ID: 29580515
[TBL] [Abstract][Full Text] [Related]
76. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin.
Selig DJ; DeLuca JP; Li Q; Lin H; Nguyen K; Scott SM; Sousa JC; Vuong CT; Xie LH; Livezey JR
Drug Metab Pers Ther; 2020 Mar; 35(1):. PubMed ID: 32134728
[TBL] [Abstract][Full Text] [Related]
77. Harnessing probiotics capability to combat Salmonella Heidelberg and improve intestinal health in broilers.
Hoepers PG; Nunes PLF; Almeida-Souza HO; Martins MM; Carvalho RDO; Dreyer CT; Aburjaile FF; Sommerfeld S; Azevedo V; Fonseca BB
Poult Sci; 2024 Jul; 103(7):103739. PubMed ID: 38678973
[TBL] [Abstract][Full Text] [Related]
78. Preparation of
Shu G; Li B; Dai C; Chen L; Yang X; Lei Z; Zhang M; Guo Y
Prep Biochem Biotechnol; 2022; 52(9):1078-1086. PubMed ID: 35108154
[No Abstract] [Full Text] [Related]
79. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae.
Edwards-Ingram L; Gitsham P; Burton N; Warhurst G; Clarke I; Hoyle D; Oliver SG; Stateva L
Appl Environ Microbiol; 2007 Apr; 73(8):2458-67. PubMed ID: 17293506
[TBL] [Abstract][Full Text] [Related]
80. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Waitzberg D; Guarner F; Hojsak I; Ianiro G; Polk DB; Sokol H
Adv Ther; 2024 Mar; 41(3):901-914. PubMed ID: 38286962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
